Stericycle: Results for Second Quarter 2008

Stericycle, Inc., reported financial results for the second quarter of 2008.

Revenues for the quarter ended June 30, 2008 were $277.8 million, up 19.3% from $232.8 million in the same quarter last year. Acquisitions less than 12 months old contributed approximately $18.0 million to the growth in revenues for the quarter. Gross profit was $123.2 million, up 17.8% from $104.5 million in the same quarter last year. Gross profit as a percent of revenue was 44.3% versus 44.9% in the second quarter of 2007.

Net income for the second quarter of 2008 was $38.7 million or $0.44 per diluted share compared with net income of $32.0 million or $0.36 per diluted share for the second quarter of 2007.

For the six months ended June 30, 2008, revenues were $532.6 million, up 20.0% from $443.9 million in the same period last year. Gross profit was $236.7 million, up 19.1% from $198.8 million in the same period last year. Gross profit as a percent of revenues was 44.5% versus 44.8% in the same period in 2007. Earnings per diluted share increased 16.2% to $0.79 from $0.68 per diluted share in the same period last year. Earnings per diluted share for the six months ended 2008 were negatively impacted by $0.04 per diluted share related to the arbitration settlement recorded in the first quarter of 2008.

Cash flow from operations was $94.6 million for the first six months of 2008. Cash flow and increased loan balances were used to strengthen our business and funded share repurchases, acquisitions and international investments, and capital expenditures.

For more information about Stericycle, please visit our website at www.stericycle.com.



Safe Harbor Statement: Statements in this press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of medical waste collection and treatment and increases in transportation and other operating costs, as well as the other factors described in our filings with the U.S. Securities and Exchange Commission. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.


STERICYCLE, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS EXCEPT FOR SHARE AND PER SHARE DATA)


            June 30,             December 31,
            2008             2007
            (unaudited)             (audited)
ASSETS                         
Current assets:                         
Cash and cash equivalents         $     12,395         $     17,108
Short-term investments             1,128             1,256

Accounts receivable, less allowance for
doubtful accounts of $6,844 in 2008 and
$6,157 in 2007
            173,267             157,435
Deferred income taxes             11,765             13,510
Other current assets             22,106             20,967
Total current assets             220,661             210,276
Property, plant and equipment, net             202,773             193,039
Other assets:                         
Goodwill             1,093,499             1,033,333

Intangible assets, less accumulated
amortization of $12,989 in 2008 and
$12,230 in 2007
            155,695             152,689
Other             19,272             18,822
Total other assets             1,268,466             1,204,844
Total assets         $     1,691,900         $     1,608,159

LIABILITIES AND SHAREHOLDERS' EQUITY                         
Current liabilities:                         
Current portion of long-term debt         $     29,118         $     22,003
Accounts payable             33,349             40,049
Accrued liabilities             90,661             75,571

Deferred revenues
            15,104             12,095
Total current liabilities             168,232             149,718
Long-term debt, net of current portion             706,853             613,781
Deferred income taxes             137,557             125,041
Other liabilities             4,706             5,544
Shareholders' equity:                         

Common stock (par value $0.01 per share,
120,000,000 shares authorized,
85,533,724 issued and outstanding in
2008, 87,410,653 issued and outstanding
in 2007)


            855             874
Additional paid-in capital             87,889             197,462
Accumulated other comprehensive income             30,240             30,520
Retained earnings             555,568             485,219
Total shareholders' equity             674,552             714,075
Total liabilities and shareholders' equity         $     1,691,900         $     1,608,159

STERICYCLE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(IN THOUSANDS EXCEPT FOR SHARE AND PER SHARE DATA)

            Three Months Ended             Six Months Ended
            June 30,             June 30,





(unaudited)





(unaudited)
            2008             2007             2008             2007
            $           % of Rev             $           % of Rev             $           % of Rev             $           % of Rev

Revenues         $     277,786             100.0     %         $     232,845             100.0     %         $     532,570             100.0     %         $     443,894             100.0     %

Cost of revenues             154,632               55.7     %             128,328               55.1     %             295,826               55.5     %             245,141               55.2     %

Gross profit             123,154             44.3     %             104,517             44.9     %             236,744             44.5     %             198,753             44.8     %


Selling, general and administrative expenses
            50,973             18.3     %             43,267             18.6     %             97,958             18.4     %             81,046             18.3     %
Amortization             792               0.3     %             882               0.4     %             1,844               0.3     %             1,750               0.4     %

Total SG&A expense and amortization             51,765               18.6     %             44,149               19.0     %             99,802               18.7     %             82,796               18.7     %


Income from operations before acquisition integration and other expenses
            71,389             25.7     %             60,368             25.9     %             136,942             25.7     %             115,957             26.1     %

Gain on sale of assets             -             0.0     %             (1,075     )         -0.5     %             -             0.0     %             (1,898     )         -0.4     %
Impairment of fixed assets             -             0.0     %             611             0.3     %             -             0.0     %             1,261             0.3     %
Impairment of permit             -             0.0     %             228             0.1     %             -             0.0     %             228             0.1     %
Arbitration settlement and related costs             147             0.1     %             -             0.0     %             5,499             1.0     %             -             0.0     %
Acquisition integration expenses             316               0.1     %             606               0.3     %             1,029               0.2     %             919               0.2     %

Income from operations             70,926             25.5     %             59,998             25.8     %             130,414             24.5     %             115,447             26.0     %

Other income (expense):                                                                                 
Interest Income             157             0.1     %             537             0.2     %             559             0.1     %             938             0.2     %
Interest expense             (8,139     )         -2.9     %             (8,276     )         -3.6     %             (16,267     )         -3.1     %             (15,976     )         -3.6     %
Insurance proceeds             -             0.0     %             -             0.0     %             -             0.0     %             500             0.1     %
Other expense, net             (518     )         -0.2     %             (230     )         -0.1     %             (961     )         -0.2     %             (783     )         -0.2     %

Total other income (expense)             (8,500     )         -3.1     %             (7,969     )         -3.4     %             (16,669     )         -3.1     %             (15,321     )         -3.5     %

Income before income taxes             62,426             22.5     %             52,029             22.3     %             113,745             21.4     %             100,126             22.6     %

Income tax expense             23,741               8.5     %             20,031               8.6     %             43,396               8.1     %             38,741               8.7     %

Net income         $     38,685               13.9     %         $     31,998               13.7     %         $     70,349               13.2     %         $     61,385               13.8     %

Earnings per share-diluted         $     0.44                       $     0.36                       $     0.79                       $     0.68               


Weighted average number of common shares outstanding-diluted
            88,484,943                           89,956,735                           88,944,593                           90,203,819               

STERICYCLE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)

            For the six months ended
            June 30,
            2008             2007
            (unaudited)             (unaudited)
Operating Activities:                         
Net income         $     70,349             $     61,385     

Adjustments to reconcile net income to net
cash provided by operating activities:

Gain on sale of assets             -                 (1,898     )
Impairment of fixed assets             -                 1,261     
Impairment of permit intangible             -                 228     
Write-off of note receivable related to joint venture             798                 -     
Stock compensation expense             5,987                 5,074     

Excess tax benefit of disqualifying
dispositions of stock options and
exercise of non-qualified stock options
            (4,523     )             (2,444     )
Depreciation             14,793                 13,096     
Amortization             1,844                 1,750     
Deferred income taxes             11,222                 8,189     

Changes in operating assets and
liabilities, net of effect of
acquisitions:

Accounts receivable             (9,304     )             (18,613     )
Other assets             (686     )             1,913     
Accounts payable             (9,575     )             4,755     
Accrued liabilities             10,748                 (6,584     )
Deferred revenues             2,982                   2,359     

Net cash provided by operating activities             94,635                   70,471     

Investing Activities:                         
Payments for acquisitions and international                         
investments, net of cash acquired             (33,399     )             (51,529     )
Proceeds from maturity of short-term investments             129                 1,948     
Proceeds from sale of assets             -                 26,453     
Proceeds from sale of property and equipment             -                 124     
Capital expenditures             (22,977     )             (23,031     )

Net cash used in investing activities             (56,247     )             (46,035     )

Financing Activities:                         
Repayment of long-term debt             (3,760     )             (32,856     )
Net borrowings on senior credit facility             (29,700     )             49,142     
Proceeds from private placement of long-term note             100,000                 -     
Payments of deferred financing costs             (236     )             -     
Principal payments on capital lease obligations             (199     )             (341     )
Excess tax benefit of stock options exercised             4,523                 2,444     
Purchase/cancellation of treasury stock             (121,195     )             (58,661     )
Proceeds from other issuances of common stock             9,737                   9,473     

Net cash used in financing activities             (40,830     )             (30,799     )
Effect of exchange rate changes on cash             (2,271     )             (5,422     )
Net decrease in cash and cash equivalents             (4,713     )             (11,785     )
Cash and cash equivalents at beginning of period             17,108                   13,492     

Cash and cash equivalents at end of period         $     12,395               $     1,707     
Non-cash activities:                         
Net issuances of notes payable for certain acquisitions         $     30,544             $     37,215     
Net issuances of common stock for certain acquisitions             0                 365     


Contact:

Stericycle, Inc.
Frank ten Brink, 847-607-2012

Source: Stericycle, Inc.
Aktuell, seriös und kostenlos: Der ECOreporter-Newsletter. Seit 1999.
Nach oben scrollen
ECOreporter Journalistenpreise
Anmelden
x